|
244. Muller M, den Tonkelaar I, Thijssen JH, et al. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol. 2003 Dec;149(6):583-9.
245. Burger HG, Dudley EC, Robertson DM, et al. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257-75.
246. Gonzales GF, Gonez C, Villena A. Adrenopause or decline of serum adrenal androgens with age in women living at sea level or at high altitude. J Endocrinol. 2002 Apr;173(1):95-101.
247. Johnson CE, Berman JR. The role of androgens in hormone replacement therapy. Expert Opin Pharmacother. 2005 Sep;6(11):1815-31
248. Berr C, Lafont S, Debuire B, et al. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13410-5.
249. Kley HK, Nieschlag E, Wiegelmann W, et al. Sexual hormones in ageing males. Aktuelle Gerontol 1976 Feb;6(2):61-7 (in German).
250. Drafta D, Schindler AE, Stroe E, et al. Age-related changes of plasma steroids in normal adult males. J Steroid Biochem 1982 Dec;17(6):683-7
251. Suzuki K, Inaba S, Takeuchi H, et al. Endocrine environment of benign prostatic hyperplasia—relationships of sex steroid hormone levels with age and the size of the prostate. Nippon Hinyokika Gakkai Zasshi 1992 May;83(5):664-71 (in Japanese).
252. Leowattana W. DHEAS as a new diagnostic tool. Clin Chim Acta. 2004 Mar;341(1-2):1-15.
253. Kellis JT Jr, Vickery LE. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984 Sep 7;225(4666):1032-4.
254. Schottner M, Gansser D, Spiteller G. Lignans from the roots of Urtica dioica and their metabolites bind to human sex hormone binding globulin (SHBG). Planta Med 1997 Dec;63(6):529-32.
255. Dalais FS, Ebeling PR, Kotsopoulos D, et al. The effects of soy protein containing isoflavones on lipids and indices of bone resorption in post-menopausal women. Clin Endocrinol (Oxf). 2003 Jun;58(6):704–9.
256. Kardinaal AFM, Morton MS, Bruggemann-Rotgans IEM, et al. Phyto-estrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr. 1998 Nov;52(11):850–5.
257. Ho SC, Chan SG, Yi Q, et al. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res. 2001 Jul;16(7):1363-9.
258. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in post-menopausal but not premenopausal women. J Clin Endocrinol Metab. 2001 Nov;86(11):5217–21.
259. Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res. 2002 Oct;17(10):1904–12.
260. Kim MK, Chung BC, Yu VY, et al. Relationships of urinary phytoestrogen excretion to BMD in postmenopausal women. Clin Endocrinol (Oxf). 2002 Mar;56(3):321–8.
261. Chiechi LM, Secreto G, D’Amore M, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoorosis: the men’s randomized trial. Maturitas. 2002 Aug 30;42(4):295–300.
262. Alekel DL, Germain AS, Peterson CT, et al. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr. 2000 Sep;72(3):844–52.
263. Potter S, Baum J, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1375S-9.
264. Crouse III JR, Morgan T, Terry JG, et al. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med. 1999 Sep 27;159(7):2070–6.
265. Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000 Jun;71(6):1462–9.
266. Wangen KE, Duncan AM, Xu X, et al. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hyper-cholesterolemic postmenopausal women. Am J Clin Nutr. 2001 Feb;73(2):225–31.
267. Teede HJ, Dalais FS, Kotsopoulos D, et al. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo controlled study in men and post-menopausal women. J Clin Endocrinol Metab. 2001 Jul;86(7):3053–60.
268. Jayagopal V, Albertazzi P, Kilpatrick ES, et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002 Oct;25(10):1709–1714.
269. Lemay A, Dodin S, Kadri N, et al. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol. 2002 Sep;100(3):495–504.
270. Sanders TAB, Dean TS, Grainger D, et al. Moderate intakes of intact soy protein rich in isoflavones compared with ethanolextracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects. Am J Clin Nutr. 2002 Aug;76(2):373–7.
271. De Kleijn MJJ, Van der Schouw YT, Wilson PWF, et al. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal US women: the Framingham Study. J Nutr. 2002 Feb;132(2):276–82.
272. Dai Q, Franke AA, Jin F, et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):815–21.
30. File SE, Jarrett N, Fluck E, et al. Eating soya improves human memory. Psychopharmacology. 2001 Oct;157(4):430–6.
273. Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav. 2003 Jun;75(3):721–9.
274. Oerter Klein K, Janfaza M, Wong JA, et al. Estrogen bioactivity in fo-ti and other herbs used for their estrogen-like effects as determined by a recombinant cell bioassay. J Clin Endocrinol Metab. 2003 Sep;88(9):4077-9. Comment in: J Clin Endocrinol Metab. 2003 Sep;88(9):4075-6.
275. Tamir S, Eizenberg M, Somjen D, et al. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol. 2001 Sep;78(3):291-8.
276. Tamir S, Eizenberg M, Somjen D, et al. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res. 2000 Oct 15;60(20):5704-9.
277. American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Use of botanicals for management of menopausal symptoms. Obstet Gynecol. 2001 Jun;97(6):Suppl 1-11.
278. Hardy ML. Herbs of special interest to women. J Am Pharm Assoc (Wash) 2000;40:234-42 http://www.medscape.com/viewarticle/406683
279. Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol. 2003 Apr;18(3):191-5.
280. Halaska M, Beles P, Gorkow C, et al. Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. Breast. 1999 Aug;8(4):175-81.
282. Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytophar maceutical formulation containing Vitex agnus-castus. J Womens Health Gend Based Med. 2000 Apr;9(3):315-20.
283. Wuttke W, Jarry H, Christoffel V, et al. Chast tree (Vitex agnus-castus) – pharmacology and clinical indications. Phytomedicine. 2003 May;10(4):348-57.
284. Gorkow C, Wuttke W, Marz RW. Effectiveness of Vitex agnus-castus preparations. Wien Med Wochenschr. 2002;152(15-16):364-72 (in German).
285. Sliutz G, Speiser P, Schultz AM, et al. Agnus castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res. 1993 May;25(5):253-5.
286. Zenk JL, Kuskowski MA. The use of 3-acetyl-7-oxo-dehydroepiandrosterone for augmenting immune response in the elderly. Presented at meeting of FASEB, April 17, 2004.
287. Bobyleva V, Bellei M, Kneer N, et al. The effects of the ergosteroid 7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis. Arch Biochem Biophys. 1997 May 1;341(1):122-8.
288. Lardy H, Partridge B, Kneer N, et al. Ergosteroids: induction of thermogenic enzymes in liver of rats treated with steroids derived from dehydroepiandrosterone. Proc Natl Acad Sci USA. 1995 Jul 3;92(14):6617-9.
289. Wu GX, Lin YX, et al. [An experimental study(II) on the inhibition of prostatic hyperplasia by extract of seeds of Brassica alba] Zhongguo Zhong Yao Za Zhi. 2003 Jul;28(7):643-6.
290. Horn TL, Reichert MA, et al. Modulations of P450 mRNA in liver and mammary gland and P450 activities and metabolism of estrogen in liver by treatment of rats with indole-3-carbinol. Biochem Pharmacol. 2002 Aug 1;64(3):393-404.
291. Kangas L, Saarinen N, et al. Antioxidant and antitumor effects of hydroxymatairesinol (HM-3000, HMR), a lignan isolated from the knots of spruce. Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S48-S57.
292. Seeram NP, Adams LS, et al. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem. 2005 Jun;16(6):360-7. |